PRICE T ROWE ASSOCIATES INC /MD/

Position in TRVI — Trevi Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in TRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,642,263

+$870,357 QoQ

Shares Held

88,057

+36.1% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#88

of 216 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. TRVI ranks #161 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,642,263	88,057	+36.1%	Shares	Defined	2026-08-14
2026-03-31	$771,906	64,703	+28.7%	Shares	Defined	2026-05-15
2025-12-31	$629,417	50,273	+7.3%	Shares	Defined	2026-02-17
2025-09-30	$428,759	46,859	+21.5%	Shares	Defined	2025-11-14
2025-06-30	$210,879	38,552	+19.9%	Shares	Defined	2025-08-14
2025-03-31	$202,298	32,162	+27.8%	Shares	Defined	2025-05-14
2024-12-31	$103,683	25,166	+32.1%	Shares	Defined	2025-02-14
2024-09-30	$63,616	19,047	0.0%	Shares	Defined	2024-11-14
2024-06-30	$56,760	19,047	+40.5%	Shares	Defined	2024-08-14
2024-03-31	$46,785	13,561	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.